Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Explore Why Low Cost Matters In Index Funds and how even small fee differences compound over time. Practical tips to keep costs down.
26,485 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A timing mishap reveals more than a celebrity scoop—it shows how quick news can ripple through budgets and plans. Thi...
A Speedway employee admitted to processing fake coffee refunds that drained thousands from the chain. The case highli...
CoreWeave is expanding fast on the AI cloud frontier, but heavy borrowing and rising interest expenses are pulling th...
Ted Turner's launch of CNN and the dawn of nonstop coverage reshaped investing and budgeting for households. This pie...
The AI landscape is shifting from a few hardware champions to a broad ecosystem of software, cloud, and microchips. L...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
Nike faces a pivotal few years as it shifts toward direct-to-consumer and digital growth. This deep dive outlines whe...
Optimum (OPTU) is reshaping its strategy in 2026. This original analysis dives into the Q1 results, margins, and capi...
Former President Donald Trump said he would attend Game 3 of the NBA Finals but urged ordinary fans to stream it inst...
This guide reveals seven practical strategies to lower rental property expenses significantly. Learn real-world finan...
Mega AI IPOs are lining up with trillion-dollar aspirations, but a contrarian view warns that upside may hinge on elu...